Sihuan Pharmaceutical Holdings Stock Current Ratio
Sihuan Pharmaceutical Holdings fundamentals help investors to digest information that contributes to Sihuan Pharmaceutical's financial success or failures. It also enables traders to predict the movement of Sihuan Pink Sheet. The fundamental analysis module provides a way to measure Sihuan Pharmaceutical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Sihuan Pharmaceutical pink sheet.
Sihuan |
Sihuan Pharmaceutical Holdings Company Current Ratio Analysis
Sihuan Pharmaceutical's Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.
Current Sihuan Pharmaceutical Current Ratio | 2.43 X |
Most of Sihuan Pharmaceutical's fundamental indicators, such as Current Ratio, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Sihuan Pharmaceutical Holdings is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Typically, short-term creditors will prefer a high current ratio because it reduces their overall risk. However, investors may prefer a lower current ratio since they are more concerned about growing the business using assets of the company. Acceptable current ratios may vary from one sector to another, but the generally accepted benchmark is to have current assets at least as twice as current liabilities (i.e., Current Ration of 2 to 1).
CompetitionIn accordance with the recently published financial statements, Sihuan Pharmaceutical Holdings has a Current Ratio of 2.43 times. This is 16.49% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The current ratio for all United States stocks is 12.5% lower than that of the firm.
Sihuan Current Ratio Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Sihuan Pharmaceutical's direct or indirect competition against its Current Ratio to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Sihuan Pharmaceutical could also be used in its relative valuation, which is a method of valuing Sihuan Pharmaceutical by comparing valuation metrics of similar companies.Sihuan Pharmaceutical is currently under evaluation in current ratio category among its peers.
Sihuan Fundamentals
Return On Equity | -0.0487 | |||
Return On Asset | -4.0E-4 | |||
Profit Margin | (0.05) % | |||
Operating Margin | (0) % | |||
Current Valuation | 506.36 M | |||
Shares Outstanding | 9.33 B | |||
Shares Owned By Insiders | 55.02 % | |||
Shares Owned By Institutions | 4.21 % | |||
Price To Earning | 8.75 X | |||
Price To Book | 0.81 X | |||
Price To Sales | 0.41 X | |||
Revenue | 3.29 B | |||
Gross Profit | 2.45 B | |||
EBITDA | 914.73 M | |||
Net Income | 416.51 M | |||
Cash And Equivalents | 5.25 B | |||
Cash Per Share | 0.56 X | |||
Total Debt | 844.75 M | |||
Debt To Equity | 0.14 % | |||
Current Ratio | 2.43 X | |||
Book Value Per Share | 0.78 X | |||
Cash Flow From Operations | 665.29 M | |||
Earnings Per Share | 0.01 X | |||
Number Of Employees | 3.9 K | |||
Beta | 0.8 | |||
Market Capitalization | 1.2 B | |||
Total Asset | 14.5 B | |||
Retained Earnings | 5.54 B | |||
Working Capital | 4.66 B | |||
Current Asset | 6.17 B | |||
Current Liabilities | 1.51 B | |||
Z Score | 0.6 | |||
Annual Yield | 0.02 % | |||
Net Asset | 14.5 B | |||
Last Dividend Paid | 0.014 |
Currently Active Assets on Macroaxis
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Other Consideration for investing in Sihuan Pink Sheet
If you are still planning to invest in Sihuan Pharmaceutical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Sihuan Pharmaceutical's history and understand the potential risks before investing.
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |